Efficacy and safety of tafolecimab in Chinese patients with heterozygous familial hypercholesterolemia: a randomized, double-blind, placebo-controlled phase 3 trial (CREDIT-2) - Concepedia

Concepedia

Publication | Open Access

Efficacy and safety of tafolecimab in Chinese patients with heterozygous familial hypercholesterolemia: a randomized, double-blind, placebo-controlled phase 3 trial (CREDIT-2)

DOI Full Paper Access

43

Citations

19

References

2023

Year

Meng Chai, Yong‐Ming He, Zhao Wang, Xuebin Han, Guoyan Zhao, Xueping Ma, Ping Qiao, Dongmei Shi, Yuyang Liu, Wei Han,

Abstract

ClinicalTrials.gov, NCT04179669.

References

	Year	Citations

Page 1